Source link : https://newshealth.biz/health-news/fda-oks-subcutaneous-amivantamab-for-egfr-mutated-nsclc/
The subcutaneous shot carries the same indications as intravenous amivantamab but cuts administration time to minutes. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-oks-subcutaneous-amivantamab-egfr-mutated-nsclc-2025a1000zrv?src=rss Author : Publish date : 2025-12-19 05:43:00 Copyright for syndicated content belongs to the linked Source.
The post FDA OKs Subcutaneous Amivantamab for EGFR-Mutated NSCLC first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-19 05:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8